Lactate/albumin ratio prognostic value for mortality in patients older than 65 years with complicated urinary tract infection
Revista Clínica Española (English Edition) · 2023
DOI: 10.1016/j.rceng.2023.04.006 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Revista Clínica Española (English Edition), 2023. Verfasst von Manuel Madrazo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Doctor Peset University Hospital, Valencia, Spain. Hauptthemen laut MEDLINE: Lactic Acid, Sepsis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Lactate to albumin ratio (LAR) is an emerging sepsis biomarker that has been tested for mortality in patients with sepsis of different focus. Our goal is to evaluate the prognostic value of LAR in patients admitted to the hospital due to complicated urinary tract infections. METHODS: Prospective observational study of patients older than 65 years diagnosed with UTI. Area under the ROC curve, sensibility, and specificity to predict 30-day mortality were calculated for LAR, qSOFA and SOFA. RESULTS: 341 UTI cases were analyzed. 30-day mortality (20.2% vs. 6.7%, p < 0.001) and longer hospital stay (5 [4-8] vs. 4 [3-7], p 0.018) were associated with LAR ≥ 0.708. LAR has no statistically significant differences compared to qSOFA and SOFA for predicting 30-day mortality (AUROC 0.737 vs. 0.832 and 0.777 respectively, p 0.119 and p 0.496). The sensitivity of LAR was similar to the sensitivity of qSOFA and SOFA (60.8% vs. 84.4% and 82.2, respectively, p 0.746 and 0.837). However, its specificity was lower than the specificity of qSOFA (60.8% vs. 75%, p 0.003), but similar to the specificity of SOFA (60.8% vs. 57.8%, p 0.787). CONCLUSION: LAR has no significant differences with other well-stablished scores in sepsis, such as qSOFA and SOFA, to predict 30-day mortality in patients with complicated UTI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctor Peset University Hospital, Valencia, Spain.
- Doctor Peset University Hospital, Valencia, Spain. Electronic address: juan.alberola@uv.es.
- Río Hortega University Hospital, Universidad de Valladolid, Spain.
Zitieren
APA
Madrazo, M., López-Cruz, I., Piles, L., Alberola, J., Gandia, J. M., Eiros, J. M., & Artero, A. (2023). Lactate/albumin ratio prognostic value for mortality in patients older than 65 years with complicated urinary tract infection. Revista Clínica Española (English Edition). https://doi.org/10.1016/j.rceng.2023.04.006
Vancouver
Madrazo M, López-Cruz I, Piles L, Alberola J, Gandia JM, Eiros JM, et al. Lactate/albumin ratio prognostic value for mortality in patients older than 65 years with complicated urinary tract infection. Revista Clínica Española (English Edition). 2023. doi:10.1016/j.rceng.2023.04.006
BibTeX
@article{Madrazo2023,
author = {Madrazo, Manuel and López-Cruz, Ian and Piles, Laura and Alberola, Juan and Gandia, Jaume Micó and Eiros, Jose M and Artero, Arturo},
title = {Lactate/albumin ratio prognostic value for mortality in patients older than 65 years with complicated urinary tract infection},
journal = {Revista Clínica Española (English Edition)},
year = {2023},
doi = {10.1016/j.rceng.2023.04.006}
}
EUVIMED